Therapeutic effect of L-carnitine on sialic acid, soluble Fas (sFas) and other biochemical variables in hyperinsulinemic rats

Life Science Journal

Volumn 6, Issue 2, 2009, Pages 76-82

  Mahfouz, Mohamed H ^a   Ghanem, Hala M ^b   Mohamed, Mona A ^c  

^a National Institute of Diabetes and Endocrinology   (Egypt)

^b Ain Shams University   (Egypt)

^c Al Azhar University   (Egypt)

Author keywords

Fructose fed rats; Insulin resistance; L carnitine (CAR); Sialic acid; Soluble fas

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 71549155644     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989; 49(6): 1155-63.
2. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: parallels between human disease and rodent models. Diabetes Care 1991; 14(3): 195-202.
3. Park OJ, Cesar D, Faix D, Wu K, Shackleton CH, Hellerstein MK. Mechanism of fructose-induced hypertriglyceridaemia in the rats. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J 1992; 282: 753-7.
4. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48(1): 1-9.
5. Rajasekar P, Anuradha CV. Effect of L-carnitine on skeletal muscle lipids and oxidative stress in rats fed high-fructose diet. Exp Diabetes Res 2007; 2007:72741
6. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40(11): 1286-92.
7. Nayak BS, Roberts L. Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications. J Inflamm (Lond) 2006; 22: 3-17.
8. Nagata S. Fas ligand-induced apoptosis. Ann Rev Genet 1999; 33: 29-55.
9. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 1999; 157(3): 231-45.
10. Liu J, Head E, Kuratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann N Y Acad Sci 2004; 1033: 117-31.
11. Broderick TL, Quinney HA, Lopaschuk GD. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 1992; 267(6): 3758-63.
12. Bisse E, Abraham A, Stallings M, Perry RE, Abraham EC. High-performance liquid chromatographic separation and quantitation of glycosylated hemoglobin A2 as an alternate index of glycemic control. J Chromatogr 1986; 24;374 (2): 259-69.
13. Barham D, Trinder P. An important colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972; 97: 142-5.
14. Allain CC, Poon LS, Chan CSG, Richmond W, FU, P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20(4): 470-5.
15. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28(10): 2077-80.
16. 2+/dextran sulphate in its enzymatic measurement. Clin Chem 1978; 24: 931-3.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502.
18. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 1980; 46(4): 649-54.
19. Marschner I, Bottermann P, Erhardt. Group experiments on the radioimmunological insulin determination. Hormone and Metabolic Research 1974; 6: 293-6.
20. Li XY, Chow CK. An improved method for the measurement of malondialdehyde in biological samples. Lipids 1994; 29(1): 73-5.
21. Warren L. The thiobarbiturate assay for sialic acid. J Biol Chem 1959; 234: 1971-5.
22. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S and Cosic V ():.method for the measurement of antioxidant activity in human fluids. Clin Pathol 2001; 54: 356-61.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,.Turner RC. Homeostasis modelassessment: insulin resistance and.beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-9.
24. Dawson B, Trapp RG. Basic and clinical biostatistics, third edition,.pbl. Lange Medical Books/McGraw-Hill.U.S.A. 2001.
25. Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi.LA. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens 2003; 16(11 Pt 1): 973-8.
26. Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin.sensitivity of rats fed high fructose diets. J Nutr 1997; 127(1): 103-7.
27. Rajasekar P, Balasaraswathi K, Anuradha CV. Effects of L-carnitine.on RBC membrane composition and function in hyperinsulinemic.rats. Ital J Biochem 2007; 56(1): 53-60.
28. D'Alessandro ME, Chicco A, Karabatas L, Lombardo YB. Role of.skeletal muscle on impaired insulin sensitivity in rats fed a sucroserich diet: effect of moderate levels of dietary fish oil. J Nutr Biochem.2000; 11(5): 273-80.
29. Nandhini AT, Balakrishnan SD, Anuradha CV. Taurine improves lipid.profile in rats fed a high fructose-diet. Nutrition Research 2002; 22: 343-54.
30. Dai S, McNeill JH. Fructose-induced hypertension in rats is concentration-and duration-dependent. J Pharmacol Toxicol Methods 1995; 33(2): 101-7.
31. Hallfrisch J, Reiser S, Prather ES. Blood lipid distribution of hyper-insulinemic men consuming three levels of fructose. Am J Clin Nutr.1983; 37(5): 740-8.
32. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997; 14(Suppl 3): S45-9 (Review).
33. Paolisso G, Giugliano D. Oxidative stress and insulin action: is there.a relationship? Diabetologia 1996; 39(3): 357-63 (Review).
34. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 2002; 1;311(1): 76-9.
35. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74(1): 139-62.
36. Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995; 49(3): 345-61 (Review).
37. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces.nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002; 51(4): 1076-82.
38. Cosson E, Bringuier AF, Paries J, Guillot R, Vaysse J, Attali JR, Feldmann G, Valensi P. Fas/Fas-Ligand pathway is impaired in patients.with type 2 diabetes. Influence of hypertension and insulin resistance. Diabetes Metab 2005; 31: 47-54.
39. Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Hérnandez G, Egido J. Increased soluble Fas plasma levels in subjects at high cardiovascular.risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy.of ACTFAST. Arterioscler Thromb Vasc Biol 2007; 27(1): 168-74.
40. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27(3): 813-23 (Review).
41. Hangloo VK, Kaul I, Zargar HU. Serum sialic acid levels in healthy.individuals. J Postgrad Med 1990; 36(3): 140-2.